July 13, 2025 - 03:22

Small-cap stocks are currently presenting attractive investment opportunities, trading at valuations that are often lower than their large-cap counterparts. Portfolio manager Sandy Villere emphasizes that these smaller companies are well-positioned for potential gains, particularly in a climate of trade uncertainty.
Investors looking to navigate the complexities of the market may find that small-cap stocks offer a unique advantage. As larger companies face various challenges, smaller firms may be more agile and better equipped to adapt to changing economic conditions. Villere's insights suggest that focusing on these stocks could be a strategic move for those aiming to capitalize on market fluctuations.
While the overall market remains volatile, the potential for small-cap stocks to outperform larger ones could provide a valuable opportunity for savvy investors. As always, careful analysis and consideration are essential when selecting specific stocks to ensure alignment with individual investment goals.
June 3, 2026 - 07:37
Japan finance minister says ready to respond appropriately on forexTOKYO, June 3 - Japanese Finance Minister Satsuki Katayama stated on Wednesday that the government is prepared to take appropriate measures in the foreign exchange market, issuing a fresh warning...
June 2, 2026 - 17:28
Thrifts & Mortgage Finance Stocks Q1 Results: Benchmarking Franklin BSP Realty Trust (NYSE:FBRT)The close of earnings season offers a useful moment to check in on how different sectors are navigating the current economic climate. For investors keeping an eye on thrifts and mortgage finance...
June 2, 2026 - 05:00
HPE expects to achieve 2028 financial targets this year after record quarter on AI boomHewlett Packard Enterprise reported record revenue for its second fiscal quarter on Monday, driven by surging demand for AI data center infrastructure. The strong performance has led the company to...
June 1, 2026 - 02:50
This $5.5 Million Exit Raises Questions After Wave Life Sciences' Rough First QuarterA recent $5.5 million executive departure at Wave Life Sciences has drawn scrutiny following the company`s disappointing first-quarter performance. The clinical-stage biotech, which develops...